The Global Fund allocates funding to eligible countries to support HIV, TB and malaria programs and to build resilient and sustainable systems for health. These allocations are made every three years at the beginning of a new funding cycle.
The total amount available for allocations to countries depends on the funding raised during the corresponding three-year replenishment cycle.
Allocations to individual countries are calculated using a formula that is predominantly based on each country’s disease burden and economic capacity, and are refined to account for important contextual factors through a transparent and accountable qualitative adjustment process.
The Global Fund adopted a refined methodology to calculate the country allocations during the 2017-2019 funding cycle. This methodology aims to deliver the goals of the Global Fund Strategy 2017-2022 and to increase the impact of country programs that prevent, treat and care for people affected by HIV, TB and malaria and build resilient and sustainable systems for health.
The 2017-2019 allocation methodology drives an increased proportion of funding to higher burden, lower income countries, and specifically accounts for HIV epidemics among key populations, the threat of multidrug-resistant tuberculosis, and for malaria elimination efforts, while providing sustainable and paced reductions where funding is decreasing.
The full list of all country allocations is available for download:
In addition to country allocations, US$800 million is available for catalytic investments during the 2017-2019 cycle. See our Catalytic Investments page for more information.